CARTA CIENTÍFICO-CLÍNICA
Adenocarcinoma apocrino cutáneo inguinal con enfermedad de Paget extramamaria: respuesta a bloqueo dual HER2 con trastuzumab y pertuzumab
Cutaneous Apocrine Adenocarcinoma of the Groin With Extramammary Paget Disease: Response to Dual HER2 Blockade With Trastuzumab and Pertuzumab
Leído
7743
Vecesse ha leído el artículo
1775
Total PDF
5968
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 55 | 8 | 63 |
| 2025 5 | 205 | 44 | 249 |
| 2025 4 | 263 | 43 | 306 |
| 2025 3 | 255 | 29 | 284 |
| 2025 2 | 233 | 31 | 264 |
| 2025 1 | 203 | 39 | 242 |
| 2024 12 | 195 | 37 | 232 |
| 2024 11 | 236 | 71 | 307 |
| 2024 10 | 225 | 56 | 281 |
| 2024 9 | 196 | 63 | 259 |
| 2024 8 | 247 | 64 | 311 |
| 2024 7 | 231 | 43 | 274 |
| 2024 6 | 186 | 70 | 256 |
| 2024 5 | 157 | 46 | 203 |
| 2024 4 | 131 | 48 | 179 |
| 2024 3 | 182 | 66 | 248 |
| 2024 2 | 170 | 63 | 233 |
| 2024 1 | 157 | 31 | 188 |
| 2023 12 | 150 | 14 | 164 |
| 2023 11 | 163 | 41 | 204 |
| 2023 10 | 163 | 34 | 197 |
| 2023 9 | 124 | 32 | 156 |
| 2023 8 | 125 | 24 | 149 |
| 2023 7 | 151 | 39 | 190 |
| 2023 6 | 127 | 18 | 145 |
| 2023 5 | 152 | 32 | 184 |
| 2023 4 | 105 | 24 | 129 |
| 2023 3 | 108 | 35 | 143 |
| 2023 2 | 105 | 36 | 141 |
| 2022 1 | 107 | 74 | 181 |
| 2022 12 | 197 | 97 | 294 |
| 2022 11 | 93 | 40 | 133 |
| 2022 10 | 54 | 24 | 78 |
| 2022 9 | 56 | 36 | 92 |
| 2022 8 | 55 | 33 | 88 |
| 2022 7 | 49 | 27 | 76 |
| 2022 6 | 44 | 23 | 67 |
| 2022 5 | 60 | 23 | 83 |
| 2022 4 | 41 | 21 | 62 |
| 2022 3 | 56 | 38 | 94 |
| 2022 2 | 38 | 38 | 76 |
| 2021 1 | 67 | 37 | 104 |
| 2021 12 | 28 | 27 | 55 |
| 2021 11 | 23 | 56 | 79 |
Mostrar todo
